AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Toll-like receptor signals needed to reverse regulatory CD8 tolerance.

Vaccine Weekly

| July 07, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JUL 7 - (NewsRx.com & NewsRx.net) -- Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance.

According to a study from the United States, "One chief barrier to cancer immunotherapy is tumor-specific T cell tolerance. Here we compared the ability of hemagglutinin (HA)-encoding recombinant viruses versus 'HA-loaded' dendritic cells to reverse HA-specific CD8 tolerance and to protect mice from tumor challenge. Both vaccines were comparable in activating naive HA-specific CD8+ T cells."

"However, in circumstances of established tolerance, viral vaccines could break CD8 tolerance in the presence of CD4+CD25+ regulatory T cells, whereas dendritic cell-based vaccines achieved this only after removal of regulatory T cells or the co-administration of a Toll-like receptor (TLR) ligand or irrelevant virus," said Yiping Yang and collaborators at Duke University and Johns Hopkins University. "These results demonstrate that virus provides TLR signals required for bypassing regulatory T ...

Related articles from newspapers, magazines, journals, and more
Nature Immunology Publication Supports Immunological Mechanism of Action Of...
Press release article from: PR Newswire May 2, 2005 700+ words
...70). The paper, published in the June 2005 issue of Nature Immunology, demonstrates that complexes of HSPs and peptides - such...Connecticut School of Medicine, and the lead author of the Nature Immunology publication. "This study adds to considerable evidence...
MedImmune Publishes New Data in Nature Immunology and Medarex Presents...
Press release article from: M2 Presswire April 19, 2007 700+ words
...U.S. Equity News: MedImmune Publishes New Data in Nature Immunology and Medarex Presents Preclinical Data Demonstrating Potent...arthritis. Data to be published in the May 2007 issue of Nature Immunology show that HMGB1 is an essential component of DNA-immune...
Hospital for Special Surgery Investigators Publish Article in 'Nature...
News wire article from: AScribe Medicine News Service October 8, 2004 700+ words
...erythematosus, according to a recent article published in "Nature Immunology." The chemical pathway involves the body's responses...investigator in the study at HSS published Oct 3, 2004 in "Nature Immunology." The paper is titled "Amplification of IFN-alpha...
Critical Therapeutics Announces the Publication of New Preclincial HMGB1 Data...
Press release article from: Business Wire April 18, 2007 700+ words
...binding protein, will be published in the May 2007 issue of Nature Immunology. The publication demonstrates that HMGB1 is part of DNA...disease, such as sepsis. "The work described in the Nature Immunology article provides important new insight into the mechanism...
Nature Immunology Reports Antigenics' Sequencing of Heat Shock Protein Receptor.
Press release article from: PR Newswire July 27, 2000 700+ words
...his colleagues at the University of Connecticut School of Medicine. These findings are reported in the August issue of Nature Immunology. (Logo: http://www.newscom.com/cgi-bin/prnh/20000419/NYW038 ) In a commentary that accompanies the...
Climate for funding of vaccine research reviewed.
Newspaper article from: Vaccine Weekly June 30, 2004 700+ words
...recent issue of Nature Immunology. "Vaccination...published his study in Nature Immunology (A healthier climate...for the journal Nature Immunology is: Nature Publishing...was prepared by Vaccine Weekly editors from staff...
Ethics of vaccine research reviewed.
Newspaper article from: Vaccine Weekly June 30, 2004 700+ words
...recent issue of Nature Immunology. According to recent...published her review in Nature Immunology (Ethics of vaccine...for the journal Nature Immunology is: Nature Publishing...was prepared by Vaccine Weekly editors from staff...
Process controlling T cell growth and production identified.
Newspaper article from: Vaccine Weekly May 20, 2009 700+ words
...appears in the current edition of Nature Immunology (see also Baylor College of Medicine...Vaccines. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2009, Vaccine Weekly via NewsRx.com.
For more facts and information, see all results

Source: HighBeam Research, Toll-like receptor signals needed to reverse regulatory CD8 tolerance.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA